Copyright
©The Author(s) 2024.
World J Hepatol. Jan 27, 2024; 16(1): 54-64
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.54
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.54
Figure 1 Flow chart of sample selection.
HCC: Hepatocellular carcinoma; MAFLD: Metabolic-associated fatty liver disease.
Figure 2 Proportion of advanced liver fibrosis in relation to the cumulative number of metabolic conditions.
Fib-4: Fibrosis-4 index; NFS: Nonalcoholic fatty liver disease fibrosis score; MAFLD: Metabolic-associated fatty liver disease.
Figure 3 Proportion of advanced liver fibrosis in patients with single metabolic conditions.
Fib-4: Fibrosis-4 index; NFS: Nonalcoholic fatty liver disease fibrosis score; MD: Metabolic dysfunction; DM: Diabetes mellitus.
- Citation: Shaikh SS, Qazi-Arisar FA, Nafay S, Zaheer S, Shaikh H, Azam Z. Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes. World J Hepatol 2024; 16(1): 54-64
- URL: https://www.wjgnet.com/1948-5182/full/v16/i1/54.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i1.54